SCHEMBL1813403

SCHEMBL1813403

CCC(CO)CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27891010 1.00
SCHEMBL7054844 1.00
SCHEMBL276400 0.89
Alcohol SCHEMBL28947608 0.86 CACNA2D1 (0.43)
SCHEMBL27936230 0.86 CACNA2D1 (0.46)
SCHEMBL804682 0.86 CACNA2D1 (0.46)
SCHEMBL27936231 0.86 CACNA2D1 (0.46)
SCHEMBL11761433 0.86 CACNA2D1 (0.46)
SCHEMBL5144412 0.86 SLC22A6 (0.45)
Propionic Acid SCHEMBL27814482 0.84 FFAR3 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116693824-A Beta-hydroxy fatty acid ester polymer and method for preparing beta-hydroxy fatty acid ester polymer by transesterification polycondensation method 中国科学院成都有机化学有限公司 2023-09-05 CN claimed
CN-108853185-A A kind of extraction purification technology of blood-sugar-lowering effective parts 济南昊雨青田医药技术有限公司 2018-11-23 CN claimed
CN-108542968-A A kind of extraction purification technology of hypoglycemic drug 济南昊雨青田医药技术有限公司 2018-09-18 CN claimed
CN-108403837-A A kind of extraction purification technology of Traditional Chinese medicine for reducing blood glucose 济南昊雨青田医药技术有限公司 2018-08-17 CN claimed
EP-2819741-B1 SOLID DRUG IMPLANTS FOR INTRACOCHLEAR DELIVERY OF THERAPEUTICS FOR THE TREATMENT OF OTIC DISORDERS O RAY PHARMA INC (US) 2018-03-28 EP claimed
CN-105628851-B A kind of detection method of Chinese medicine preparation 九芝堂股份有限公司 2017-10-31 CN claimed
EP-1585500-B1 COATED PARTICLES FOR SUSTAINED-RELEASE PHARMACEUTICAL ADMINISTRATION ST JAMES ASS LLC/FABER RES SERIES (US) 2017-05-10 EP claimed
US-9492388-B2 Coated particles for sustained-release pharmaceutical administration ST. JAMES ASSOCIATES LLC/FABER RESEARCH SERIES (US) 2016-11-15 US claimed
US-20160250231-A1 SOLID DRUG IMPLANTS FOR INTRACOCHLEAR DELIVERY OF THERAPEUTICS FOR THE TREATMENT OF OTIC DISORDERS O-RAY PHARMA, INC. (US) 2016-09-01 US claimed
US-20150202161-A1 PROCESS FOR MANUFACTURING DRUG DELIVERY FORMULATIONS O-RAY PHARMA, INC. (US) 2015-07-23 US claimed
US-20070003619-A1 Coated particles for sustained-release pharmaceutical administration ST. JAMES ASSOCIATES LLC/FABER RESEARCH SERIES (US) 2007-01-04 US claimed
EP-1585500-A1 COATED PARTICLES FOR SUSTAINED-RELEASE PHARMACEUTICAL ADMINISTRATION St. James Associates Llc/Faber Research Series (US) 2005-10-19 EP claimed
WO-2004058223-A1 COATED PARTICLES FOR SUSTAINED-RELEASE PHARMACEUTICAL ADMINISTRATION ST. JAMES ASSOCIATES LLC/FABER RESEARCH SERIES (US) 2004-07-15 WO claimed
CN-1260779-A Epsilon-caprolactam composition and by products UNION CARBIDE CHEMICALS & PROD (US) 2000-07-19 CN claimed
EP-0975590-A1 EPSILON CAPROLACTAM COMPOSITIONS AND BYPRODUCTS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 2000-02-02 EP claimed
US-5925754-A REDUCTING BY-PRODUCTS; CHEMICAL INTERMEDIATE FOR NYLON UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1999-07-20 US claimed
WO-1998046564-A1 EPSILON CAPROLACTAM COMPOSITIONS AND BYPRODUCTS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-10-22 WO claimed
EP-0390887-A1 ENERGY SUBSTRATE CONTAINING HYDROXY CARBOXYLIC ACID KABIVITRUM AB (SE) 1990-10-10 EP claimed
EP-0363337-A1 Energy substrate containing hydroxycarboxylic acid KABIVITRUM AB (SE) 1990-04-11 EP claimed
WO-1990002547-A1 ENERGY SUBSTRATE CONTAINING HYDROXY CARBOXYLIC ACID KABIVITRUM AB (SE) 1990-03-22 WO claimed